Nautilus Biotechnology Inc logo

NAUT

Nautilus Biotechnology Inc

$2.46

Earnings Summary

Net Profits
$-14.69Mn

Highlights

Net Profits:

Nautilus Biotechnology Inc’s net profit fell -37.11% since last year same period to $-14.69Mn in the Q2 2022. On a quarterly growth basis, Nautilus Biotechnology Inc has generated 6.81% jump in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Nautilus Biotechnology Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.17
EPS Estimate Current Year
-0.17

Highlights

EPS Estimate Current Quarter:

Nautilus Biotechnology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.17 - a -6.25% fall from last quarter’s estimates.

EPS Estimate Current Year:

Nautilus Biotechnology Inc’s earning per share (EPS) estimates for the current year stand at -0.17.

Key Ratios

Key ratios of the Nautilus Biotechnology Inc post its Q2 2022 earnings

Earning Per Share (EPS)
-0.12
Return on Assets (ROA)
-0.1
Return on Equity (ROE)
-0.17
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Nautilus Biotechnology Inc’s earning per share (EPS) jumped 36.84% since last year same period to -0.12 in the Q2 2022. This indicates that the Nautilus Biotechnology Inc has generated 36.84% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Nautilus Biotechnology Inc’s return on assets (ROA) stands at -0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nautilus Biotechnology Inc’s return on equity (ROE) stands at -0.17.

Dividend Per Share (DPS):

Nautilus Biotechnology Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-02
-0.17
-0.12
29.41%
2022-05-03
-0.16
-0.13
18.75%

Company Information

Organisation
Nautilus Biotechnology Inc
Headquarters
2701 Eastlake Avenue East, Seattle, WA, United States, 98102